Bristol-Myers Squibb Company

Company overview

Bristol-Myers Squibb Company (BMS or 'the company') is a global biopharmaceutical company. BMS was formed by the merger of Bristol Myers and Squibb Pharmaceuticals in 1989, a move which at the time created the world's second largest drug company. The company operates in the Americas, Europe, Japan, Asia, Australia, the Middle East and Africa. BMS is headquartered in New York City, New York, and employed 28,000 people as of December 31, 2013.

The company recorded revenues of $16,385 million during the financial year ended December 2013 (FY2013), a decrease of 7% over FY2012. The operating profit of the company was $2,891 million in FY2013, an increase of 23.5% over FY2012. The net profit was $2,563 million in FY2013, an increase of 30.8% over FY2012.

In February 2014, BMS sold its interest in the global diabetes alliance to its partner, AstraZeneca.

Key facts

345 Park Avenue , New York City , New York 10154 , USA

http://www.bms.com

New York ticker: BMY

No. employees: 28000

Turnover: 16,385,000,000 (USD)

Financial year end: December

Summary

  • Key facts
  • Overview
  • Business Description
  • History
  • Key Employees and Biographies
  • Location and Subsidiaries
  • Top Competitors
  • Major Products and Services

SWOT Profiles

This SWOT analysis company profile is the essential source for top level data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Scope of this research

  • Provides all the crucial company information required for business and competitor intelligence needs.
  • Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams.
  • Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Key reasons to purchase this research

  • Support sales activities by understanding your customers' businesses better
  • Qualify prospective partners and suppliers
  • Keep fully up to date on your competitors' business structure, strategy and prospects
  • Obtain the most up to date company information available

Company Profile

Published by
MarketLine
Published on
24 Jul 2014
Product code
86A2800A-36A5-4B33-90B5-9AFB0A8FCCB4
Pages
Please wait...

$175

Multi-user License $438